Advertisement

Reactions Weekly

, Volume 1734, Issue 1, pp 23–23 | Cite as

Afatinib/icotinib

Acquired drug resistance, rash and diarrhoea: case report
Case report
  • 8 Downloads

Reference

  1. Zhang P, et al. Combined therapy with osimertinib and afatinib in a lung adenocarcinoma patient with EGFR T790M mutation and multiple HER2 alterations after resistance to icotinib: A case report. Thoracic Cancer 9: 1774-1777, No. 12, Dec 2018. Available from: URL: http://doi.org/10.1111/1759-7714.12889 - ChinaCrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations